Orthopediatrics (KIDS) Net Income towards Common Stockholders Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Orthopediatrics | 394.83 Mn | 346.02 Mn | 43.39 Mn | -0.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.26% |
| Dec 31, 2025 | 37.13% |
| Sep 30, 2025 | -48.67% |
| Jun 30, 2025 | -17.98% |
| Mar 31, 2025 | -36.57% |
| Dec 31, 2024 | -140.16% |
| Sep 30, 2024 | -72.49% |
| Jun 30, 2024 | -108.91% |
| Mar 31, 2024 | -14.68% |
| Dec 31, 2023 | 14.74% |
| Sep 30, 2023 | -124.76% |
| Jun 30, 2023 | -766.67% |
| Mar 31, 2023 | 25.21% |
| Dec 31, 2022 | -11,000.00% |
| Sep 30, 2022 | 943.83% |
| Jun 30, 2022 | 91.13% |
| Mar 31, 2022 | 12.32% |
| Dec 31, 2021 | 100.51% |
| Sep 30, 2021 | 51.60% |
| Jun 30, 2021 | 60.24% |
| Mar 31, 2021 | -109.89% |
| Dec 31, 2020 | -158.11% |
| Sep 30, 2020 | -70.38% |
| Jun 30, 2020 | -260.85% |
| Mar 31, 2020 | -63.74% |
| Dec 31, 2019 | -119.98% |
| Sep 30, 2019 | -42.84% |
| Jun 30, 2019 | 2.75% |
| Mar 31, 2019 | 39.60% |
| Dec 31, 2018 | 83.63% |
| Sep 30, 2018 | 38.27% |
| Jun 30, 2018 | 1.03% |
| Mar 31, 2018 | -84.43% |
| Dec 31, 2017 | -185.08% |
| Sep 30, 2017 | -25.61% |